[Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer].
OBJECTIVE
To study the therapeutic result of operation combined chemotherapy for stage IIIa non-small cell lung cancer.


METHODS
From January 2000 to December 2003, the data of 83 cases with stage IIIa non-small cell lung cancer undergoing operation combined chemotherapy and 33 cases with stage IIIa non-small cell lung cancer undergoing non-operative therapy were retrospectively analyzed. The median survival time and the 1-, 2-, 3- year survival rates of the two groups were compared by the Kaplan-Meier method.


RESULTS
The median survival time of the operation group was 20.3 months, and the 1-, 2-, 3- year survival rates were 85%, 70%, and 35% respectively. The median survival time of the non-operation group was 14.5 months and the 1-, 2-, 3- year survival rates were 75%, 33%, and 15% respectively.


CONCLUSIONS
The therapeutic result of the operation combined chemotherapy for the stage IIIa non-small cell lung cancer is better than that of the non-operative therapy obviously.
Wang
Wei
W
Department of Thoracic Surgery, Naval General Hospital of People's Libration Army, Beijing 100037, China. wangyr02@hotmail.com
Li
Hui
H
Shang
Li-qun
LQ
Li
Xue-chang
XC
Li
Jun
J
Song
Wei-an
WA
Wen
Feng
F
D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods*; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome